Patient-Specific iPSC Derived Endothelial Cells Uncover Pathways that Protect Against Pulmonary Hypertension in BMPR2 Mutation Carriers

In familial pulmonary arterial hypertension (FPAH) the autosomal dominant disease-causing BMPR2 mutation is only 20% penetrant, suggesting that genetic variation provides modifiers that alleviate the disease. Here, we used comparison of induced pluripotent stem cell derived endothelial cells (iPSC-E...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Stem Cell
Autores principales: Gu, Mingxia, Shao, Ning-Yi, Sa, Silin, Li, Dan, Termglinchan, Vittavat, Ameen, Mohamed, Karakikes, Ioannis, Sosa, Gustavo, Grubert, Fabian, Lee, Jaecheol, Cao, Aiqin, Taylor, Shalina, Ma, Yu, Zhao, Zhixin, Chappell, James, Hamid, Rizwan, Austin, Eric D., Gold, Joseph D, Wu, Joseph C, Snyder, Michael P, Rabinovitch, Marlene
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500296/
https://ncbi.nlm.nih.gov/pubmed/28017794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2016.08.019
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares